MAPK3 and endometrial cancer: Together, our studies suggest that type II endometrial cancer cell migration/invasion involves both MEK-ERK1/2-SNAIL-mediated E-cadherin down-regulation and SMAD2/3-SMAD4-mediated integrin β3 up-regulation.